Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Intrathecal Neostigmine as an Adjuvant to Bupivacaine in Ameliorating Post-Dural Puncture Headache in Elective Caesarian Section: A Prospective Randomized Controlled Clinical Trial

NCT05289323 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT05289323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05289323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Intrathecal Neostigmine as an Adjuvant to Bupivacaine in Ameliorating Post-Dural Puncture Headache in Elective Caesarian Section: A Prospective Randomized Controlled Clinical Trial
Lead sponsor
Alexandria University
Phase
Phase 4
Overall status
Completed
Start date
April 25, 2022
Completion date
July 25, 2023
Enrollment
722 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-dural puncture headache